In The News

In The News

GEN| October 27, 2017
Companion Diagnostic Development Gets More Complex for Immune Therapies and Other Indications Outside Oncology
DDN News | August 2017
The study, entitled “Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury,” is a proof-of-concept paper showing how the scientists combined Quanterix’s Single Molecule Array Detection technology, or Simoa, and…
Genetic Engineering and Biotechnology News | July 26, 2017
Improved Cancer Immunodiagnostics and Immunotherapeutics Depend on Biomarker Discovery
Diagnostics World | September 2, 2016
When it comes to our health, we will be most successful at advancing disease diagnostics if we can marry the benefits of genetic testing with protein testing, says Quanterix CEO and Executive Chairman, Kevin Hrusovsky. Click to read his article in Diagnostics World.
November 18, 2015
American Laboratory Read the article at www.americanlaboratory.com.
September 10, 2013
Outsourced Pharma and Clinical Leader Read the article at www.clinicalleader.com
November 4, 2011
Read the article at www.prnewswire.com
2010
Read the article at www.fiercebiomarkers.com